博文
一种靶向呼吸道合胞病毒保守表位的保护性单克隆抗体
||
一种靶向呼吸道合胞病毒保守表位的保护性单克隆抗体
https://www.ebiotrade.com/newsf/2024-2/20240201064226370.htm
http://www.pubmedplus.cn/P/SearchQuickResult?wd=5e9ace15-d506-4624-9203-d7659a81522d
| 01. | Antibodies, Monoclonal | 314 篇 | 100.000% |
| 02. | Antibodies, Monoclonal, Humanized | 314 篇 | 100.000% |
| 03. | Antiviral Agents | 314 篇 | 100.000% |
| 04. | Respiratory Syncytial Virus Infections | 314 篇 | 100.000% |
| 05. | Palivizumab | 310 篇 | 98.726% |
| 06. | Humans | 309 篇 | 98.408% |
| 07. | Infant | 201 篇 | 64.013% |
| 08. | Infant, Newborn | 185 篇 | 58.917% |
| 09. | Hospitalization | 96 篇 | 30.573% |
| 10. | Female | 81 篇 | 25.796% |
https://kns.cnki.net/kns8s/search?classid=WD0FTY92&kw=Synagis&korder=SU
(1)
(1)
(1)
(1)
(1)
(1)
https://fx.wanfangdata.com.cn/keytrends/detail?theme_name=Synagis
https://blog.sciencenet.cn/blog-280034-1420123.html
上一篇：真菌脑膜炎耐药和治疗策略研发
下一篇：梅花诗 行书
